Objective-To characterize clinical and clinicopathologic findings, response
to treatment, and causes of systemic hypertension in cats with hypertensiv
e retinopathy. Design-Retrospective study.
Animals-69 cats with hypertensive retinopathy.
Procedure-Medical records from cats with systemic hypertension and hyperten
sive retinopathy were reviewed.
Results-Most cats (68.1%) were referred because of vision loss; retinal det
achment, hemorrhage, edema, and degeneration were common findings. Cardiac
abnormalities were detected in 37 cats, and neurologic signs were detected
in 20 cats. Hypertension was diagnosed concurrently with chronic renal fail
ure (n = 22), hyperthyroidism (5), diabetes mellitus (2), and hyperaldoster
onism (1). A clearly identifiable cause for hypertension was not detected i
n 38 cats; 26 of these cats had mild azotemia, and 12 did not have renal ab
normalities. Amlodipine decreased blood pressure in 31 of 32 cats and impro
ved ocular signs in 18 of 26 cats.
Conclusions and Clinical Relevance-Retinal lesions, caused predominantly by
choroidal injury, are common in cats with hypertension. Primary hypertensi
on in cats may be more common than currently recognized. Hypertension shoul
d be considered in older cats with acute onset of blindness; retinal edema,
hemorrhage, or detachment; cardiac disease; or neurologic abnormalities, C
ats with hypertension-induced ocular disease should be evaluated for renal
failure, hyperthyroidism, diabetes mellitus, and cardiac abnormalities. Blo
od pressure measurements and funduscopic evaluations should be performed ro
utinely in cats at risk for hypertension (preexisting renal disease, hypert
hyroidism, and age > 10 years). Amlodipine is an effective antihypertensive
agent in cats.